RMD News: Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks - 25th Jun 2024, 2:12am

annb0t

Top 20
(Bloomberg) -- The new class of weight-loss drugs are being tested as cure-alls for everything from knee replacements to liver disease and throwing corners of the stock market into disarray.

Most Read from Bloomberg

How Long Can High Rates Last? Bond Markets Say Maybe Forever Jain Raises $5.3 Billion in Biggest Hedge Fund Debut Since 2018 Nvidia Sales Grow So Fast That Wall Street Can’t Keep Up BuzzFeed Struggles to Sell Owner of Hit YouTube Show ‘Hot Ones’ Volatility Grips Stoc...

>>> Read more: Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks
 
Top Bottom